- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00505778
A Comparison of Once a Day Dose Compared to 2 Doses/Day
April 15, 2013 updated by: Warner Chilcott
A Multi-center, Investigator-blinded, Randomized, 12-month, Parallel-group, Non-inferiority Study to Compare the Efficacy of 1.6 to 2.4 g Asacol® Therapy QD Versus Divided Dose (BID) in the Maintenance of Remission of Ulcerative Colitis
The purpose of this study is to compare the efficacy in maintaining remission of ulcerative colitis between a once daily (QD) Asacol regimen and a divided, twice daily (BID) Asacol dosing regimen.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Currently, in the US, Asacol therapy is indicated in divided doses for the maintenance of remission of ulcerative colitis at 1.6 g/day.
A once daily dose is potentially beneficial to patients and physicians alike.
This study will answer the following questions about once daily dosing: (1) does efficacy differ between once daily and twice daily dosing, (2) do patients prefer a once daily dosing regimen, and (3) is compliance better?
This study will confirm whether there are benefits to once daily dosing beyond increased convenience.
In order to understand how the QD regimen compares to BID in a "real life" practice setting, the patient will remain on the total daily dose of Asacol (1.6 g/day to 2.4 g/day) on which they were maintained in remission, but will be assigned to either a QD or BID regimen.
This is an investigator-blinded study.
Study Type
Interventional
Enrollment (Actual)
1027
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Quebec, Canada, G1L 3L5
- Research Facility
-
Quebec, Canada, G1S 4L8
- Research Facility
-
-
British Columbia
-
Abbotsford, British Columbia, Canada, V2S 3N5
- Research Facility
-
-
Ontario
-
Guelph, Ontario, Canada, N1H 3R3
- Research Facility
-
Hamilton, Ontario, Canada, L8N 4A6
- Research Facility
-
Ottawa, Ontario, Canada, K1H 8L6
- Research Facility
-
Toronto, Ontario, Canada, M4N 3M5
- Research Facility
-
Toronto, Ontario, Canada, M5G 2O4
- Research Facility
-
-
Quebec
-
Montreal, Quebec, Canada, H1T 2M4
- Research Facility
-
Montreal, Quebec, Canada, H3T 1E2
- Research Facility
-
-
-
-
-
Ponce, Puerto Rico, 00717
- Research Facility
-
San Juan, Puerto Rico, 00936
- Research Facility
-
-
-
-
Alabama
-
Athens, Alabama, United States, 35611
- Research Facility
-
Birmingham, Alabama, United States, 35209
- Research Facility
-
Birmingham, Alabama, United States, 35294
- Research Facility
-
Dothan, Alabama, United States, 26305-1156
- Research Facility
-
-
Arizona
-
Phoenix, Arizona, United States, 85050
- Research Facility
-
Scottsdale, Arizona, United States, 85259
- Research Facility
-
Tucson, Arizona, United States, 85712
- Research Facility
-
Tuscon, Arizona, United States, 85711
- Research Facility
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Research Facility
-
Lowell, Arkansas, United States, 72745
- Research Facility
-
-
California
-
Anaheim, California, United States, 92801
- Research Facility
-
Beverly Hills, California, United States, 90210
- Research Facility
-
Chico, California, United States, 95926
- Research Facility
-
Encinitas, California, United States, 92024
- Research Facility
-
Folsum, California, United States, 95630
- Research Facility
-
La Mesa, California, United States, 91941
- Research Facility
-
Lancaster, California, United States, 93534
- Research Facility
-
Long Beach, California, United States, 90806
- Research Facility
-
Los Angeles, California, United States, 90015
- Research Facility
-
Los Angeles, California, United States, 90045
- Research Facility
-
Madera, California, United States, 93637
- Research Facility
-
Merced, California, United States, 95340
- Research Facility
-
Mission Hills, California, United States, 91345
- Research Facility
-
Monterey, California, United States, 93940
- Research Facility
-
Murrieta, California, United States, 92562
- Research Facility
-
Oakland, California, United States, 94609
- Research Facility
-
Orange, California, United States, 92868
- Research Facility
-
Palm Springs, California, United States, 92262
- Research Facility
-
San Carlos, California, United States, 94070
- Research Facility
-
San Diego, California, United States, 92123
- Research Facility
-
San Diego, California, United States, 92103
- Research Facility
-
San Diego, California, United States, 92117
- Research Facility
-
San Francisco, California, United States, 94117
- Research Facility
-
San Francisco, California, United States, 94122
- Research Facility
-
Torrance, California, United States, 90503
- Research Facility
-
Torrance, California, United States, 90505
- Research Facility
-
Upland, California, United States, 91786
- Research Facility
-
-
Colorado
-
Englewood, Colorado, United States, 80113
- Research Facility
-
Golden, Colorado, United States, 80401
- Research Facility
-
Lafayette, Colorado, United States, 80026
- Research Facility
-
Pueblo, Colorado, United States, 81008
- Research Facility
-
-
Connecticut
-
Hartford, Connecticut, United States, 06106
- Research Facility
-
Meriden, Connecticut, United States, 06451
- Research Facility
-
New Haven, Connecticut, United States, 06510
- Research Facility
-
Norwalk, Connecticut, United States, 06851
- Research Facility
-
Torrington, Connecticut, United States, 06790
- Research Facility
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20060
- Research Facility
-
-
Florida
-
Aventura, Florida, United States, 33180
- Research Facility
-
Fort Lauderdale, Florida, United States, 33308
- Research Facility
-
Gainesville, Florida, United States, 32607
- Research Facility
-
Hollywood, Florida, United States, 33021
- Research Facility
-
Jacksonville, Florida, United States, 32207
- Research Facility
-
Jacksonville, Florida, United States, 32223
- Research Facility
-
Largo, Florida, United States, 33777
- Research Facility
-
Maitland, Florida, United States, 32751
- Research Facility
-
Naples, Florida, United States, 34102
- Research Facility
-
New Port Richey, Florida, United States, 34652
- Research Facility
-
North Miami Beach, Florida, United States, 33162
- Research Facility
-
Orlando, Florida, United States, 32806
- Research Facility
-
Palm Harbor, Florida, United States, 34684
- Research Facility
-
Port Orange, Florida, United States, 32129
- Research Facility
-
St Petersburg, Florida, United States, 33711
- Research Facility
-
St. Petersburg, Florida, United States, 33707
- Research Facility
-
Tallahassee, Florida, United States, 32308
- Research Facility
-
Tampa, Florida, United States, 33613
- Research Facility
-
Tampa, Florida, United States, 33607
- Research Facility
-
Trinity, Florida, United States, 34655
- Research Facility
-
Winter Park, Florida, United States, 32789
- Research Facility
-
Zephyrhills, Florida, United States, 33542
- Research Facility
-
-
Georgia
-
Atlanta, Georgia, United States, 30342-5000
- Research Facility
-
Columbus, Georgia, United States, 31904
- Research Facility
-
Decatur, Georgia, United States, 30033
- Research Facility
-
Marietta, Georgia, United States, 30060
- Research Facility
-
Marietta, Georgia, United States, 30067
- Research Facility
-
Newnan, Georgia, United States, 30263
- Research Facility
-
Savannah, Georgia, United States, 31406
- Research Facility
-
-
Idaho
-
Boise, Idaho, United States, 83704
- Research Facility
-
Idaho Falls, Idaho, United States, 83404
- Research Facility
-
-
Illinois
-
Arlington Heights, Illinois, United States, 60005
- Research Facility
-
Berwyn, Illinois, United States, 60402
- Research Facility
-
Chicago, Illinois, United States, 60637
- Research Facility
-
Elgin, Illinois, United States, 60123
- Research Facility
-
Highland Park, Illinois, United States, 60036
- Research Facility
-
Hoffman Estates, Illinois, United States, 60169
- Research Facility
-
Homewood, Illinois, United States, 60430
- Research Facility
-
Lake Barrington, Illinois, United States, 60010
- Research Facility
-
Oak Lawn, Illinois, United States, 60453
- Research Facility
-
Peoria, Illinois, United States, 61602
- Research Facility
-
Urbana, Illinois, United States, 61801
- Research Facility
-
-
Indiana
-
Anderson, Indiana, United States, 46016
- Research Facility
-
Bloomington, Indiana, United States, 47403
- Research Facility
-
Indianapolis, Indiana, United States, 46202
- Research Facility
-
Indianapolis, Indiana, United States, 46260
- Research Facility
-
South Bend, Indiana, United States, 46601
- Research Facility
-
-
Iowa
-
Clive, Iowa, United States, 50325
- Research Facility
-
Davenport, Iowa, United States, 52807
- Research Facility
-
Waterloo, Iowa, United States, 50701
- Research Facility
-
-
Kansas
-
Pratt, Kansas, United States, 67124
- Research Facility
-
Topeka, Kansas, United States, 66606
- Research Facility
-
Whichita, Kansas, United States, 67214
- Research Site
-
-
Kentucky
-
Bowling Green, Kentucky, United States, 42101
- Research Facility
-
Louisville, Kentucky, United States, 40202
- Research Facility
-
Louisville, Kentucky, United States, 40291
- Research Facility
-
-
Louisiana
-
Alexandria, Louisiana, United States, 71301
- Research Facility
-
Lafayette, Louisiana, United States, 70503
- Research Facility
-
Metairie, Louisiana, United States, 70006
- Research Facility
-
Monroe, Louisiana, United States, 71201
- Research Facility
-
Shreveport, Louisiana, United States, 71103
- Research Facility
-
-
Maine
-
Bangor, Maine, United States, 04401
- Research Facility
-
-
Maryland
-
Chevy Chase, Maryland, United States, 20815
- Research Facility
-
College Park, Maryland, United States, 20740
- Research Facility
-
Greenbelt, Maryland, United States, 20770
- Research Facility
-
Hagerstown, Maryland, United States, 21740
- Research Facility
-
Hollywood, Maryland, United States, 20636
- Research Facility
-
Lutherville, Maryland, United States, 21093
- Research Facility
-
Reisterstown, Maryland, United States, 21136
- Research Facility
-
Rockville, Maryland, United States, 20850
- Research Facility
-
Rockville, Maryland, United States, 20854
- Research Facility
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Research Facility
-
Boston, Massachusetts, United States, 02215
- Research Facility
-
Braintree, Massachusetts, United States, 02184
- Research Facility
-
Southbridge, Massachusetts, United States, 01550
- Research Facility
-
-
Michigan
-
Chesterfield, Michigan, United States, 48047
- Research Facility
-
Detroit, Michigan, United States, 48201
- Research Facility
-
Kalamazoo, Michigan, United States, 49048
- Research Facility
-
Troy, Michigan, United States, 48098
- Research Facility
-
West Bloomfied, Michigan, United States, 48322
- Research Facility
-
Wyoming, Michigan, United States, 49519
- Research Facility
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Research Facility
-
-
Mississippi
-
Tupelo, Mississippi, United States, 38801
- Research Facility
-
-
Missouri
-
Cape Girardeau, Missouri, United States, 63703-6364
- Research Facility
-
Columbia, Missouri, United States, 65212
- Research Facility
-
Jefferson City, Missouri, United States, 65109
- Research Facility
-
Mexico, Missouri, United States, 65265
- Research Facility
-
St Louis, Missouri, United States, 63128
- Research Facility
-
-
Nevada
-
Las Vegas, Nevada, United States, 89147
- Research Facility
-
-
New Hampshire
-
Somersworth, New Hampshire, United States, 03878
- Research Facility
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- Research Facility
-
Cedar Knolls, New Jersey, United States, 07927
- Research Facility
-
Egg Harbor Township, New Jersey, United States, 08234-5857
- Research Facility
-
Hackensack, New Jersey, United States, 07601
- Research Site
-
Ocean, New Jersey, United States, 07712
- Research Facility
-
South Plainfield, New Jersey, United States, 07080
- Research Facility
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87109
- Research Facility
-
-
New York
-
Babylon, New York, United States, 11702
- Research Facility
-
Binghamton, New York, United States, 13903
- Research Facility
-
Brooklyn, New York, United States, 11215
- Research Facility
-
Brooklyn, New York, United States, 11234
- Research Facility
-
Cheektowaga, New York, United States, 14225
- Research Facility
-
Cortland, New York, United States, 13045
- Research Facility
-
Forest Hills, New York, United States, 10128
- Research Facility
-
Garden City, New York, United States, 11530
- Research Facility
-
Great Neck, New York, United States, 11021
- Research Facility
-
Great Neck, New York, United States, 11023
- Research Facility
-
Lake Success, New York, United States, 11042
- Research Facility
-
New York, New York, United States, 10016
- Research Facility
-
New York, New York, United States, 10028
- Research Facility
-
Pittsford, New York, United States, 14534
- Research Facility
-
Port Jefferson Station, New York, United States, 11776
- Research Facility
-
Rochester, New York, United States, 14621
- Research Facility
-
Rochester, New York, United States, 14625
- Research Facility
-
-
North Carolina
-
Boone, North Carolina, United States, 28607
- Research Facility
-
Charlotte, North Carolina, United States, 28204
- Research Facility
-
Greensboro, North Carolina, United States, 27403
- Research Facility
-
Greenville, North Carolina, United States, 27834
- Research Facility
-
Jacksonville, North Carolina, United States, 28546
- Research Facility
-
Kinston, North Carolina, United States, 28501
- Research Facility
-
Morganton, North Carolina, United States, 28655
- Research Facility
-
Mt Airy, North Carolina, United States, 27030
- Research Facility
-
Newbern, North Carolina, United States, 28562
- Research Facility
-
Pinehurst, North Carolina, United States, 28374
- Research Facility
-
Raleigh, North Carolina, United States, 27607
- Research Facility
-
Wilmington, North Carolina, United States, 28401
- Research Facility
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Research Facility
-
-
Ohio
-
Akron, Ohio, United States, 44302
- Research Facility
-
Canton, Ohio, United States, 44718
- Research Facility
-
Cincinnati, Ohio, United States, 45242
- Research Facility
-
Cincinnati, Ohio, United States, 45219
- Research Facility
-
Cleveland, Ohio, United States, 44195
- Research Facility
-
Dayton, Ohio, United States, 45440
- Research Facility
-
Dayton, Ohio, United States, 45415
- Research Facility
-
Mentor, Ohio, United States, 44060
- Research Facility
-
Toledo, Ohio, United States, 43617
- Research Facility
-
Westlake, Ohio, United States, 44145
- Research Facility
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74104
- Research Facility
-
-
Oregon
-
Portland, Oregon, United States, 97225
- Research Facility
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18104
- Research Facility
-
Beaver Falls, Pennsylvania, United States, 15010
- Research Facility
-
Clairton, Pennsylvania, United States, 15025
- Research Facility
-
Indiana, Pennsylvania, United States, 15701
- Research Facility
-
Lancaster, Pennsylvania, United States, 17604
- Research Facility
-
Philadelphia, Pennsylvania, United States, 19106
- Research Facility
-
Phoenixville, Pennsylvania, United States, 19460
- Research Facility
-
Pittsburgh, Pennsylvania, United States, 15213
- Research Facility
-
Pittsburgh, Pennsylvania, United States, 15243
- Research Facility
-
Sewickley, Pennsylvania, United States, 15143
- Research Facility
-
Souderton, Pennsylvania, United States, 18964
- Research Facility
-
Uniontown, Pennsylvania, United States, 15401
- Research Facility
-
-
Rhode Island
-
Warwick, Rhode Island, United States, 02888
- Research Facility
-
-
South Carolina
-
Columbia, South Carolina, United States, 29203
- Research Facility
-
Columbia, South Carolina, United States, 29204
- Research Facility
-
Greer, South Carolina, United States, 29651
- Research Facility
-
-
Tennessee
-
Jackson, Tennessee, United States, 38301
- Research Facility
-
Jackson, Tennessee, United States, 38305
- Research Facility
-
Memphis, Tennessee, United States, 38104
- Research Facility
-
Morristown, Tennessee, United States, 37814
- Research Facility
-
-
Texas
-
Amarillo, Texas, United States, 79119
- Research Facility
-
Fort Worth, Texas, United States, 76104
- Research Facility
-
Greenville, Texas, United States, 75401
- Research Facility
-
Houston, Texas, United States, 77054
- Research Facility
-
Houston, Texas, United States, 77004
- Research Facility
-
Houston, Texas, United States, 77090
- Research Facility
-
Lewisville, Texas, United States, 75057
- Research Facility
-
Longview, Texas, United States, 75605
- Research Facility
-
Odessa, Texas, United States, 79761
- Research Facility
-
Pasadena, Texas, United States, 77504
- Research Facility
-
Plano, Texas, United States, 75075
- Research Facility
-
San Antonio, Texas, United States, 78229
- Research Facility
-
-
Utah
-
Ogden, Utah, United States, 84405
- Research Facility
-
Salt Lake City, Utah, United States, 84107
- Research Facility
-
West Valley City, Utah, United States, 84120
- Research Facility
-
-
Virginia
-
Alexandria, Virginia, United States, 22306
- Research Facility
-
Chesapeake, Virginia, United States, 23320
- Research Facility
-
Fairfax, Virginia, United States, 22031
- Research Facility
-
Norfolk, Virginia, United States, 23502
- Research Facility
-
Virginia Beach, Virginia, United States, 23454
- Research Facility
-
Winchester, Virginia, United States, 22601
- Research Facility
-
-
Washington
-
Seattle, Washington, United States, 98133
- Research Facility
-
Spokane, Washington, United States, 99204
- Research Facility
-
Tacoma, Washington, United States, 98405
- Research Facility
-
Wenatchee, Washington, United States, 98801
- Research Facility
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53209
- Research Facility
-
Monroe, Wisconsin, United States, 53566
- Research Facility
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Documented history of ulcerative colitis that has been successfully maintained in remission for at least 3 months prior to study entry
- At least one flare in the past 18 months
- Utilizing a stable maintenance dose of oral Asacol of 1.6 g/day up to 2.4 g/day (stable dose is defined as the same dose for the past 3 months)
- Females must be postmenopausal or surgically sterile or have a negative urine pregnancy test and practice acceptable contraception
Exclusion Criteria:
- History of or current renal disease
- History of hepatic disease
- History of allergy or hypersensitivity to salicylates, aminosalicylates
- Treatment with immunomodulatory therapy, biologic therapy or corticosteroids within 90 days of screening
- Received any antidiarrheals, antispasmodics, or antibiotic within 1 month of screening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Mesalamine (Asacol) Once-Daily
an oral, once daily (QD) mesalamine regimen (1.6 - 2.4 g/day)
|
Mesalamine tablets, 1.6-2.4
g/day taken orally once a day for 52 weeks
Other Names:
|
Active Comparator: Mesalamine (Asacol) Twice-Daily
an oral, twice daily (BID) mesalamine regimen (1.6 - 2.4 g/day)
|
Mesalamine tablets, 1.6-2.4
g/day, taken twice daily for 52 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Patients Remaining in Remission at Month 6, ITT Population, Determined by the Simple Clinical Colitis Activity Index (SCCAI)
Time Frame: 6 months
|
Remission defined as SCCAI <5.
Simple Clinical Colitis Activity Index: minimum score 0, maximum score 19, reflects disease activity over the 24 hours prior to completion.
Composite Score: bowel frequency (day, 0-3) (night, 0-2), defecation urgency (0-3), blood in stool (0-3), general well being (0-4), extracolonic features (arthritis, pyoderma gangrenosum, erythema nodosum, uveitis - 1 per manifestation).
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Patients Remaining in Remission at Month 3, ITT Population
Time Frame: 3 months
|
Remission defined as SCCAI < 5. Simple Clinical Colitis Activity Index: minimum score 0, maximum score 19, reflects disease activity over the 24 hours prior to completion.
Composite Score: bowel frequency (day, 0-3) (night, 0-2), defecation urgency (0-3), blood in stool (0-3), general well being (0-4), extracolonic features (arthritis, pyoderma gangrenosum, erythema nodosum, uveitis - 1 per manifestation).
|
3 months
|
Percentage of Patients Remaining in Remission at Month 12, ITT Population
Time Frame: 12 months
|
Remission defined as SCCAI score < 5. Simple Clinical Colitis Activity Index: minimum score 0, maximum score 19, reflects disease activity over the 24 hours prior to completion.
Composite Score: bowel frequency (day, 0-3) (night, 0-2), defecation urgency (0-3), blood in stool (0-3), general well being (0-4), extracolonic features (arthritis, pyoderma gangrenosum, erythema nodosum, uveitis - 1 per manifestation).
|
12 months
|
Number of Subjects Who Relapse/Flare Within 6 Months, ITT Population
Time Frame: 6 months
|
Relapse/flare is defined as SCCAI >= 5. Simple Clinical Colitis Activity Index: minimum score 0, maximum score 19, reflects disease activity over the 24 hours prior to completion.
Composite Score: bowel frequency (day, 0-3) (night, 0-2), defecation urgency (0-3), blood in stool (0-3), general well being (0-4), extracolonic features (arthritis, pyoderma gangrenosum, erythema nodosum, uveitis - 1 per manifestation).
|
6 months
|
Total MARS (Medication Adherence Report Scale) Questionnaire Scores, ITT Population, Month 6
Time Frame: 6 months
|
MARS: Composite score for the following statements: I change how many times per day I take my medicine, I forget to use it, I stop taking it for a while, I only use it when I am having active symptoms, I decide to miss out on a dose, I take less than instructed, I take more than instructed, I avoid using it if I can, I use it regularly every day (reverse scored): 5-never, 4-rarely, 3-sometimes, 2-often, 1-very often.
Minimum score 9, maximum score 45.
|
6 months
|
Percentage of Participants Indicating Ulcerative Colitis in Remission (Patient Defined Remission Index), ITT Population, Month 6
Time Frame: 6 months
|
Is your ulcerative colitis in remission (not active)?
Y/N
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Tom G Todaro, MD, Procter and Gamble
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2007
Primary Completion (Actual)
July 1, 2009
Study Completion (Actual)
July 1, 2009
Study Registration Dates
First Submitted
July 20, 2007
First Submitted That Met QC Criteria
July 20, 2007
First Posted (Estimate)
July 23, 2007
Study Record Updates
Last Update Posted (Estimate)
April 22, 2013
Last Update Submitted That Met QC Criteria
April 15, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Gastrointestinal Diseases
- Gastroenteritis
- Colonic Diseases
- Intestinal Diseases
- Inflammatory Bowel Diseases
- Ulcer
- Colitis
- Colitis, Ulcerative
- Physiological Effects of Drugs
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Mesalamine
Other Study ID Numbers
- 2007021
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ulcerative Colitis
-
Ferring PharmaceuticalsCompletedActive Ulcerative Colitis | Remission of Ulcerative ColitisCanada
-
Palatin Technologies, IncRecruitingUlcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute | UlcerativeUnited States
-
Theravance BiopharmaCompletedUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateUnited States, Georgia, Moldova, Republic of, Romania
-
Rise Therapeutics LLCUniversity of Colorado, Denver; Mayo ClinicRecruitingUlcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic MildUnited States
-
Assistance Publique - Hôpitaux de ParisMRSU 938 - Research Center of Saint AntoineNot yet recruitingPediatric Ulcerative Colitis in RemissionFrance
-
Protagonist Therapeutics, Inc.CompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereUnited States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
-
Theravance BiopharmaCompletedActive Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy SubjectsUnited States
-
Altheus Therapeutics, Inc.UnknownUlcerative Colitis | Left-sided Ulcerative Colitis | Distal Ulcerative ColitisUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University Medical Center Groningen; UMC UtrechtRecruitingUlcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis AcuteNetherlands
-
Immune PharmaceuticalsUnknownUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateIsrael
Clinical Trials on Mesalamine Once-Daily
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Kowa Company, Ltd.Recruiting
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Slovakia
-
Inflazyme Pharmaceuticals LtdCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Dr. Reddy's Laboratories LimitedCompleted
-
PfizerTerminatedParkinson DiseaseUnited States, France, Israel, Germany
-
Spectrum Pharmaceuticals, IncTerminated
-
Kowa Company, Ltd.Completed
-
Kowa Company, Ltd.Completed